Lv71
4560 积分 2023-05-12 加入
An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics
16天前
已完结
An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics
16天前
已完结
Mechanistic basis for protection against fatty liver disease by CIDEB loss-of-function mutations
1个月前
已完结
Hyperfibrinogenemia as a cause of prolonged thrombin clotting time
1个月前
已完结
Nonclinical Evaluation of Compound‐Related Alterations in Hemostasis
1个月前
已完结
Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH
1个月前
已完结
Supaglutide alleviates hepatic steatosis in monkeys with spontaneous MASH
2个月前
已关闭
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2个月前
已完结
Deep Phenotyping of a Spontaneous Nonhuman Primate Model of Diabetic Macular Edema
2个月前
已关闭
Uricosuric agents decrease the plasma urate level in rats by concomitant treatment with topiroxostat, a novel xanthine oxidoreductase inhibitor
4个月前
已完结
皖公网安备34019202002308
